AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 201 min read$PATH

Dines Daniel sold $22.5M of PATH

Dines Daniel (CEO and Chairman) sold 1,402,347 shares of UiPath, Inc. (PATH) at $16.07 ($22.54M total) on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dines Daniel
Published Aug 20, 2026, 12:27 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$PATH
Bearish
medium confidence
Mentioned
$PATH
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The disclosed sale provides fresh data on insider holdings and potential market impact.

02

Market read

Large insider sell may influence short‑term price action and sentiment.

03

What to watch

10b5-1 plans are pre‑arranged and may not reflect current sentiment.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑08‑19

Background

Form 4 filing discloses insider transactions required by SEC.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

CEO Dines Daniel sold 1.4M shares for $22.5M via a 10b5-1 plan.

Expected impact

potential short-term downside pressure

Evidence & confidence

Sale size is material for a mid‑cap and executed under a pre‑arranged plan, suggesting possible concerns.

Market effects

Sector

RPA/automation sector may see heightened scrutiny of insider activity.

Regional

U.S. tech stocks could experience slight pullback.

Global

Limited to investors tracking UiPath and related automation peers.

Counterpoint

What could challenge this read

Insider sale could be routine liquidity event, not a bearish signal.

Key entities

  • Company
    UiPath, Inc.

    Robotic process automation software provider.

  • Individual
    Dines Daniel

    CEO and Chairman of UiPath.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PATH insider trading history →

Related articles

AUG 6
$PLTRHighAI 9/10

Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally

Palantir Technologies reported Q2 2026 revenue of $1.94B, up 92.8% YoY, beating $1.81B consensus, and raised FY2026 revenue guidance to about $8.15B. U.S. commercial total contract value reached a record $2.1B. Shares rose about 16% to $145.50 after Deutsche Bank upgraded to Buy with a $200 target; C3.ai and UiPath did not rally.

yahoo.com4 min
AUG 4
$PLTRMed

JFrog, Zscaler, Palo Alto Networks, Shopify, and UiPath Shares Are Soaring, What You Need To Know

In Tuesday premarket trading, Palantir’s (PLTR) reported Q2 results and raised full-year revenue outlook drove a broad rally in enterprise software and cybersecurity peers. The article cites Palantir’s 26% jump and links the move to lower Treasury yields after geopolitical de-escalation. It also lists gains for JFrog (FROG), Zscaler (ZS), Palo Alto Networks (PANW), Shopify (SHOP), and UiPath (PATH).

financialcontent.com4 min
JUL 30
$PATHMed

UiPath (NYSE:PATH) Shares Fall as Q2 Outlook Indicates Reduced ARR Growth

NEW YORK, July 30, 2026, 2:01 p.m. EDT — Shares of UiPath NYSE:PATH declined after the company forecasted slower additions to annualized recurring revenue for the second quarter. The stock dropped 3.3% to $12.18 in early U.S. trading. Initial estimates indicate Q2 guidance suggests net new ARR between $28 million and $33 million. Initial estimate: market value, adjusted for cash, is approximately 2.8 times the projected revenue for fiscal 2027. UiPath shares declined even as U.S.

ts2.tech6 min
JUL 27
$PATHMed

PATH Stock Slips As UBS Trims Price Target

UiPath (PATH) shares were up about 7.3% on AI automation optimism, but UBS cut its price target to $12 from $13 while keeping a Neutral rating. Street consensus remains Hold with a mean target near $13.47 versus a price around $10.81. The article also cites UiPath’s annual revenue of about $1.61B and recent quarterly net income of about $22.5M.

stockstotrade.com5 min
JUL 1
$PATHMed

UiPath shares rebound as Wall Street warms to its AI-agent pivot

UiPath shares rebounded about 15% over five days after the company reported its first-quarter GAAP operating profit of $28m and GAAP profit for the first time in a first quarter, following a loss a year earlier. Revenue rose 17% to $418m; annual recurring revenue reached $1.9bn (+12%). UiPath is pivoting to AI agents, including its WorkFusion acquisition.

thenextweb.com4 min
JUN 3
$PATHMedAI 9/10

Stock Market Today, June 1: Stock Market Today, June 1: UiPath Rises After Strong Q1 Results and Raised Outlook

UiPath (NYSE:PATH) rose 11.77% to close at $13.10 after reporting fiscal Q1 2027 results and raising guidance, according to the company. The report cited 17% year-over-year revenue growth to $418 million, annual recurring revenue of $1.901 billion (+12%), and positive GAAP operating income of $28 million. Trading volume was 65.5 million shares.

finance.yahoo.com4 min